Ownership Summary
Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) appears in 8 institutional 13F filings for the quarter ending March 2026.
- Collectively, these holders controlled 45.8% of Aimei Health Technology's outstanding shares in March 2026, up from 24.6% in December 2025.
- They decreased total shares held in Aimei Health Technology by -0.27% from last quarter, and the number of investors in AFJK decreased 52.94% annually.
- During the quarter, 2 of these 8 funds increased positions in AFJK, 3 reduced exposure, and 3 held steady.
- In total, institutional investors held 974.69K shares in Aimei Health Technology as of March 2026, down by 2.67K shares quarter on quarter, and down 3.65Mn shares year over year.
- First Trust Capital Management L.P. is the top holder of Aimei Health Technology as of March 31, 2026, with 680.0K shares representing 31.98% of outstanding stock.
- Leading buyers of Aimei Health Technology shares for the quarter ending March 2026 were Federation des caisses Desjardins du Quebec (185), Morgan Stanley (18).
- Leading sellers of Aimei Health Technology shares for the quarter ending March 2026 were UBS Group AG (1.3K), Karpus Management, Inc. (950), OSAIC HOLDINGS, INC. (624).
- Business Quant data shows the 8 biggest positions in Aimei Health Technology as of March 2026 are held by First Trust Capital Management L.P. (680.0K), GLAZER CAPITAL, LLC (133.74K), Clear Street Group Inc. (83.34K), Karpus Management, Inc. (77.12K), OSAIC HOLDINGS, INC. (238), Federation des caisses Desjardins du Quebec (185), Morgan Stanley (50), UBS Group AG (14).